(Q27851648)

2

Sally E Carty

0 references

Linwah Yip

11

Linwah Yip

0 references

Marina N Nikiforova

9

Marina N Nikiforova

0 references

Gina M Howell

1

Gina M Howell

0 references

Michaele J Armstrong

3

Michaele J Armstrong

0 references

Shane O Lebeau

4

Shane O Lebeau

0 references

Steven P Hodak

5

Steven P Hodak

0 references

Michael Stang

7

Michael T Stang

0 references

Kelly McCoy

8

Kelly L McCoy

0 references

author name string

Christopher Coyne

Annals of Surgical Oncology

6

0 references

publication date

December 2011

0 references

published in

0 references

volume

18

0 references

page(s)

3566-71

0 references

issue

13

0 references

exact match

https://scigraph.springernature.com/pub.10.1245/s10434-011-1781-5

0 references

cites work

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

Specific features of differentiated thyroid carcinoma in patients over 70 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

The prevalence and prognostic value of BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5